Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin alfa in severe traumatic brain injury
NCT00375869Phase 2Completed
- Sponsor
- Royal Alexandra Hospital
- Start
- Nov 2006
- Primary completion
- Dec 2009
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
A Phase 2 trial of darbepoetin alfa in traumatic brain injury (TBI), sponsored by Royal Alexandra Hospital. Started Nov 2006; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT00375869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00375869.